[November 21, 2014]

IASIS Healthcare Announces Fourth Quarter and Year-End 2014 Results

IASIS Healthcare® LLC ("IASIS" or the "Company") today announced financial and operating results for the fiscal fourth quarter and year ended September 30, 2014. The Company's discontinued operations in the accompanying consolidated financial statements have been excluded from segment information, consolidated financial and operating data and supplemental consolidated statements of operations information for the fiscal fourth quarters and years ended September 30, 2014 and 2013.

Key Financial & Operating Results

Fourth Quarter Fiscal 2014

Total revenue for the fourth quarter totaled $655.4 million, an increase of 16.4% compared to $563.0 million in the prior year quarter. Adjusted EBITDAR, which excludes rent expense associated with the sale-leaseback of certain hospital real estate, for the fourth quarter totaled $73.9 million, an increase of 16.5% compared to $63.5 million in the prior year quarter.

In the fourth quarter, admissions increased 0.8% and adjusted admissions increased 2.6%, each compared to the prior year quarter. Net patient revenue per adjusted admission in the fourth quarter increased 5.2% compared to the prior year quarter.

Acute care revenue for the fourth quarter increased 7.6% compared to the prior year quarter. Premium and service revenues at Health Choice for the fourth quarter, excluding the effect of $4.7 million of revenue associated with the new health insurer fee ("HIF"), increased 41.0% compared to the prior year quarter. Total lives served across all product lines increased 81.3% to 340,900, compared to 188,000 in the prior year quarter, while health plan lives increased 18.8% compared to the same prior year period.

"We are very pleased with the strong results in both our acute care and managed care operations. We are seeing continued improvements in employment and other economic factors in our local markets, solid fundamental operating performance, as well as continued improvements in our payor and service line mix," said IASIS Healthcare President and Chief Executive Officer Carl Whitmer. "We are excited about our plans for the upcoming 2015 fiscal year, which include growing our core provider business, expanding our managed care operations and continuing integration of our business lines in a manner that improves population health, results in more cost efficient care and drives value."

Fiscal Year 2014

Total revenue for the year ended September 30, 2014, totaled $2.5 billion, an increase of 10.9% compared to $2.3 billion in the prior year. Adjusted EBITDAR for the year ended September 30, 2014, totaled $287.7 million, an increase of 13.4% compared to $253.8 million in the prior year. Adjusted EBITDAR for fiscal 2014 includes $4.8 million in start-up related costs at Health Choice and $3.5 million of compensation expense associated with a special bonus paid to certain members of the Company's leadership team in recognition of the completion of certain strategic initiatives. Additionally, the prior year was negatively affected by $6.1 million of changes in reimbursement estimates associated with the Company's Houston market.

For the year ended September 30, 2014, admissions decreased 2.5% and adjusted admissions increased 0.8%, each compared to the prior year. Net patient revenue per adjusted admission for the year ended September 30, 2014, increased 4.4% compared to the prior year.

Acute care revenue for the year ended September 30, 2014, increased 4.8% compared to the prior year. Premium and service revenues at Health Choice for the year ended September 30, 2014, excluding the effect of $8.2 million of revenue associated with the new HIF, increased 28.0% compared to the prior year.

Cash flows provided by continuing operations for the year ended September 30, 2014, totaled $77.2 million, compared to cash flows provided by continuing operations of $101.2 million in the prior year. Cash flows provided by operations for the year ended September 30, 2014, were affected by the payment of $22.3 million in income taxes and other transaction costs, as well as additional rent payments of $22.2 million, both associated with the Company's sale-leaseback of certain hospital real estate that occurred at the end of fiscal 2013, and the continued delay of certain supplemental and other program reimbursement in Texas and Arizona.

On November 11, 2014, in connection with the Company's efforts to execute on both short- and long-term growth initiatives in its core markets and at Health Choice, the Company's managed care solutions business, IASIS signed a definitive agreement to sell its Nevada operations.

Conference Call

A listen-only simulcast and 30-day replay of IASIS' fourth quarter and year-end 2014 conference call will be available by clicking the "For Investors" link on the Company's Web site at www.iasishealthcare.com beginning at 11:00 a.m. Eastern Time on November 21, 2014. A copy of this press release will also be available on the Company's Web site.

IASIS Healthcare, located in Franklin, Tennessee, is a leading provider and manager of high-quality, affordable healthcare services in urban and suburban markets. With total annual total revenue of approximately $2.5 billion, IASIS owns and operates 16 acute care hospitals, one behavioral health hospital, several outpatient service facilities, 134 physician clinics, and Health Choice, a provider-owned, managed care organization and insurer delivering healthcare services to over 340,000 members through multiple health plans, accountable care networks and managed care solutions. IASIS offers a variety of access points for convenient patient care in numerous regions across the U.S., including: Salt Lake City, Utah; Phoenix, Arizona; five cities in Texas, including Houston and San Antonio; and West Monroe, Louisiana. For more information on IASIS, please visit the Company's Web site at www.iasishealthcare.com.

Some of the statements we make in this press release are forward-looking within the meaning of the federal securities laws, which are intended to be covered by the safe harbors created thereby. Those forward-looking statements include all statements that are not historical statements of fact and those regarding our intent, belief or expectations including, but not limited to, future financial and operating results, the Company's plans, objectives, expectations and other statements that are not historical facts. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results in future periods to differ materially from those anticipated in the forward-looking statements. These risk factors and uncertainties are more fully described in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2013, and other filings with the Securities and Exchange Commission.

Although we believe that the assumptions underlying the forward-looking statements contained in this press release are reasonable, any of these assumptions could prove to be inaccurate, and, therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, you should not regard the inclusion of such information as a representation by the Company or any other person that our objectives and plans will be achieved. We undertake no obligation to publicly release any revisions to any forward-looking statements contained herein to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events.

Adjusted EBITDAR represents adjusted EBITDA before rent expense associated with the sale-leaseback of certain hospital real estate. Adjusted EBITDA represents net earnings (loss) from continuing operations before interest expense, income tax expense (benefit), depreciation and amortization, stock-based compensation and related expenses, gain (loss) on disposal of assets and management fees. Management fees represent monitoring and advisory fees paid to TPG, the Company's majority financial sponsor, and certain other members of IASIS Investment LLC. Management routinely calculates and communicates adjusted EBITDA and believes that it is useful to investors because it is commonly used as an analytical indicator within the healthcare industry to evaluate hospital performance, allocate resources and measure leverage capacity and debt service ability. In addition, the Company uses adjusted EBITDA as a measure of performance for its business segments and for incentive compensation purposes. Neither adjusted EBITDAR nor adjusted EBITDA should be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from such EBITDAR and EBITDA measures are significant components in understanding and assessing financial performance. Neither EBITDAR nor EBITDA measures should be considered in isolation or as an alternative to net earnings, cash flows generated by operating, investing, or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. Such EBITDAR and EBITDA measures may not be comparable to similarly titled measures of other companies. A table describing adjusted EBITDAR and adjusted EBITDA and reconciling net earnings (loss) from continuing operations to such EBITDAR and EBITDA measures is included in this press release in the attached Supplemental Consolidated Statements of Operations Information.

[ Back To TMCnet.com's Homepage ]